Synopsis
Synopsis
0
CEP/COS
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Benfothiamine
2. Benphothiamine
3. Btmp-benfo
4. Milgamma
5. Neurostop
6. S-benzoylthiamine Monophosphate
1. 22457-89-2
2. Benphothiamine
3. Betivina
4. Benzoylthiamine Monophosphate
5. S-benzoylthiamine O-monophosphate
6. S-benzoylthiamine Monophosphate
7. Benfotiamina
8. Benfotiaminum
9. 22457-89-2 (free Acid)
10. S-[(z)-2-[(4-amino-2-methylpyrimidin-5-yl)methyl-formylamino]-5-phosphonooxypent-2-en-3-yl] Benzenecarbothioate
11. (z)-s-(2-(n-((4-amino-2-methylpyrimidin-5-yl)methyl)formamido)-5-(phosphonooxy)pent-2-en-3-yl) Benzothioate
12. S-[2-{[(4-amino-2-methylpyrimidin-5-yl)methyl](formyl)amino}-5-(phosphonooxy)pent-2-en-3-yl] Benzenecarbothioate
13. Sr-01000872627
14. N-((4-amino-2-methyl-5-pyrimidinyl)methyl)-n-(4-hydroxy-2-mercapto-1-methyl-1-butenyl)formamide S-benzoate O-phosphate
15. Chebi:41039
16. Prestwick_68
17. Biotamin (tn)
18. Mfcd00057343
19. Prestwick2_000654
20. Prestwick3_000654
21. Benfotiamine (jan/inn)
22. Bspbio_000687
23. Schembl188070
24. Bpbio1_000757
25. Chembl4303665
26. Schembl19184708
27. Hms1570c09
28. Hms2097c09
29. Hms3714c09
30. Zinc2015559
31. Stl453586
32. Akos015920320
33. Ac-8280
34. Ccg-220654
35. Db11748
36. Ncgc00179477-01
37. (3z)-4-{n-[(4-amino-2-methylpyrimidin-5-yl)methyl]carbonylamino}-3-(phenylcarb Onylthio)pent-3-enyl Dihydrogen Phosphate
38. 57b892
39. A15020
40. D01255
41. Sr-01000872627-1
42. Sr-01000872627-2
43. 137-74-6
44. S-[(2z)-2-{[(4-amino-2-methylpyrimidin-5-yl)methyl](formyl)amino}-5-(phosphonooxy)pent-2-en-3-yl] Benzenecarbothioate
45. S-{(1z)-2-[[(4-amino-2-methyl-5-pyrimidinyl)methyl](formyl)amino]-1-[2-(phosphonooxy)ethyl]-1-propenyl} Benzenecarbothioate
46. S-{(1z)-2-[[(4-amino-2-methyl-5-pyrimidinyl)methyl](formyl)amino]-1-[2-(phosphonooxy)ethyl]-1-propenyl} Benzenecarbothioate, Aldrichcpr
Molecular Weight | 466.4 g/mol |
---|---|
Molecular Formula | C19H23N4O6PS |
XLogP3 | 0.5 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 10 |
Exact Mass | 466.10759264 g/mol |
Monoisotopic Mass | 466.10759264 g/mol |
Topological Polar Surface Area | 181 Ų |
Heavy Atom Count | 31 |
Formal Charge | 0 |
Complexity | 697 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Adjuvants, Immunologic
Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)
Chelating Agents
Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. (See all compounds classified as Chelating Agents.)
A - Alimentary tract and metabolism
A11 - Vitamins
A11D - Vitamin b1, plain and in combination with vitamin b6 and b12
A11DA - Vitamin b1, plain
A11DA03 - Benfotiamine
Gonane has API manufacturing expertise in new-age Corticosteroids, Hormones and other pharma raw materials.
Date of Issue : 2022-08-11
Valid Till : 2025-06-26
Written Confirmation Number : WC-0054
Address of the Firm :
Registrant Name : Palm East Co., Ltd.
Registration Date : 2023-10-06
Registration Number : 20210323-211-J-662(8)
Manufacturer Name : Ami Lifesciences Private Limited
Manufacturer Address : Block No. 82/B, ECP Road At & Post. Karakhadi, Tal-Padra, City : Karakhadi-391450, Dist : Vadodara, Gujarat State, India
Chynops Pharma is an ideal sourcing partner for high-quality APIs, advanced intermediates, speciality chemicals & excipients.
Reliable Spanish CDMO Delivering High-Quality APIs and Intermediates with Excellence, Flexibility, and Regulatory Compliance.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38067
Submission : 2023-02-20
Status : Active
Type : II
Date of Issue : 2022-03-11
Valid Till : 2025-03-11
Written Confirmation Number : WC-0522
Address of the Firm :
Date of Issue : 2022-04-13
Valid Till : 2025-04-12
Written Confirmation Number : WC-0524
Address of the Firm :
Date of Issue : 2020-08-10
Valid Till : 2022-07-02
Written Confirmation Number : WC-0194A2
Address of the Firm :
Registrant Name : SSFarm Co., Ltd.
Registration Date : 2024-05-24
Registration Number : 20210420-211-J-947(1)
Manufacturer Name : Kekule Pharma Limited
Manufacturer Address : Sy.No. 180/1 to 15, MIA, Kazipally, Jinnaram Mandal, Sangareddy-502 319, Telangana State, India
Date of Issue : 2022-09-07
Valid Till : 2025-07-02
Written Confirmation Number : WC-248
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38067
Submission : 2023-02-20
Status : Active
Type : II
Benfotiamine (for manufacturing purposes only)
Registration Number : 217MF11200
Registrant's Address : 3 Himata, Toyama City, Toyama Prefecture
Initial Date of Registration : 2005-12-12
Latest Date of Registration : 2007-05-15
Registration Number : 217MF10852
Registrant's Address : Osaka Prefecture, Osaka City, Suminoe Ward, Nanko Kita 1-19-40
Initial Date of Registration : 2005-11-01
Latest Date of Registration : 2007-04-27
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Details:
The follow-up trial will expand on previous work completed at BNI, suggesting that high levels of benfotiamine significantly slowed the rate of functional decline in participants with mild cognitive impairment or early AD.
Lead Product(s): Benfotiamine
Therapeutic Area: Neurology Brand Name: Undisclosed
Study Phase: Phase IIProduct Type: Small molecule
Sponsor: National Institutes of Health
Deal Size: $45.0 million Upfront Cash: Undisclosed
Deal Type: Funding July 07, 2022
Lead Product(s) : Benfotiamine
Therapeutic Area : Neurology
Highest Development Status : Phase II
Partner/Sponsor/Collaborator : National Institutes of Health
Deal Size : $45.0 million
Deal Type : Funding
Details : The follow-up trial will expand on previous work completed at BNI, suggesting that high levels of benfotiamine significantly slowed the rate of functional decline in participants with mild cognitive impairment or early AD.
Brand Name : Undisclosed
Molecule Type : Small molecule
Upfront Cash : Undisclosed
July 07, 2022
Regulatory Info : Generic
Registration Country : India
Benphothiamine; Mecobalamin; Pyridoxine; Riboflavin; Thioctic Acid; Vitamin D3
Brand Name : \n\n
Dosage Form : CAPSULE
Dosage Strength : 150MG; 5MG; 5MG; 1000MCG; 100MCG; 500IU
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Regulatory Info :
Registration Country : Ukraine
Benphothiamine; Pyridoxal Phosphate
Brand Name : Vitaxon
Dosage Form : Coated Tablet
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Ukraine
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Softgelatin Capsule
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Benfotiamine; Methylcobalamin; alpha-Lipoic Acid; Inositol; Folic Acid; Pyridoxine Hydrochloride
Brand Name :
Dosage Form : Softgelatin Capsule
Dosage Strength : 100MG; 1000MCG; 200MCG; 100MG; 1.5MG; 3MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : Generic
Registration Country : Turkey
Brand Name :
Dosage Form : TABLET
Dosage Strength : 300MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Turkey
Regulatory Info : Generic
Registration Country : Turkey
Brand Name :
Dosage Form : ENTERIC FILM COATED TABLET
Dosage Strength : 100MG; 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Turkey
Regulatory Info :
Registration Country : Turkey
Brand Name : NEVRALON-B
Dosage Form : FILM COATED TABLET
Dosage Strength : 150MG
Packaging : 20 OR 30 TABLETS
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Turkey
Regulatory Info :
Registration Country : Turkey
Brand Name : NEVRALON-B
Dosage Form : FILM COATED TABLET
Dosage Strength : 300MG
Packaging : 20 OR 30 TABLETS
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Turkey
Regulatory Info :
Registration Country : Turkey
Brand Name : NEVRALON ADVANCE
Dosage Form : ENTERIC FILM COATED TABLET
Dosage Strength : 100MG; 100MF
Packaging : 20 OR 30 TABLETS
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Turkey
Regulatory Info :
Registration Country : India
Mecobalamin; Thioctic Acid; Pyridoxine; Folic Acid; Inositol; Benphothiamine
Brand Name :
Dosage Form : Capsule
Dosage Strength : 1000MCG; 200MG; 3MG; 1.5MG; 100MG; 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : Ukraine
Benphothiamine; Pyridoxal Phosphate
Brand Name : Vitaxon
Dosage Form : Coated Tablet
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Ukraine
Regulatory Info : Generic
Registration Country : Turkey
Brand Name :
Dosage Form : TABLET
Dosage Strength : 300MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Turkey
Regulatory Info : Generic
Registration Country : Turkey
Brand Name :
Dosage Form : ENTERIC FILM COATED TABLET
Dosage Strength : 100MG; 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : Turkey
Regulatory Info : Generic
Registration Country : India
Benphothiamine; Mecobalamin; Pyridoxine; Riboflavin; Thioctic Acid; Vitamin D3
Brand Name : \n\n
Dosage Form : CAPSULE
Dosage Strength : 150MG; 5MG; 5MG; 1000M...
Packaging :
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : India
Packaging :
Regulatory Info : Generic
Benphothiamine; Mecobalamin; Pyridoxine; Riboflavin; Thioctic Acid; Vitamin D3
Dosage : CAPSULE
Dosage Strength : 150MG; 5MG; 5MG; 1000M...
Brand Name : \n\n
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Softgelatin Capsule
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Softgelatin Capsule
Dosage Strength : 150MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Benfotiamine; Methylcobalamin; alpha-Lipoic Acid; Inositol; Folic Acid; Pyridoxine Hydrochloride
Brand Name :
Dosage Form : Softgelatin Capsule
Dosage Strength : 100MG; 1000MCG; 200MCG...
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Benfotiamine; Methylcobalamin; alpha-Lipoic Acid; Inositol; Folic Acid; Pyridoxine Hydrochloride
Dosage : Softgelatin Capsule
Dosage Strength : 100MG; 1000MCG; 200MCG...
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : Turkey
Brand Name : NEVRALON-B
Dosage Form : FILM COATED TABLET
Dosage Strength : 150MG
Packaging : 20 OR 30 TABLETS
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Turkey
Packaging : 20 OR 30 TABLETS
Regulatory Info :
Dosage : FILM COATED TABLET
Dosage Strength : 150MG
Brand Name : NEVRALON-B
Approval Date :
Application Number :
Registration Country : Turkey
Regulatory Info :
Registration Country : Turkey
Brand Name : NEVRALON-B
Dosage Form : FILM COATED TABLET
Dosage Strength : 300MG
Packaging : 20 OR 30 TABLETS
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Turkey
Packaging : 20 OR 30 TABLETS
Regulatory Info :
Dosage : FILM COATED TABLET
Dosage Strength : 300MG
Brand Name : NEVRALON-B
Approval Date :
Application Number :
Registration Country : Turkey
Regulatory Info :
Registration Country : Turkey
Brand Name : NEVRALON ADVANCE
Dosage Form : ENTERIC FILM COATED TA...
Dosage Strength : 100MG; 100MF
Packaging : 20 OR 30 TABLETS
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Turkey
Packaging : 20 OR 30 TABLETS
Regulatory Info :
Dosage : ENTERIC FILM COATED TA...
Dosage Strength : 100MG; 100MF
Brand Name : NEVRALON ADVANCE
Approval Date :
Application Number :
Registration Country : Turkey
Regulatory Info :
Registration Country : India
Mecobalamin; Thioctic Acid; Pyridoxine; Folic Acid; Inositol; Benphothiamine
Brand Name :
Dosage Form : Capsule
Dosage Strength : 1000MCG; 200MG; 3MG; 1...
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Mecobalamin; Thioctic Acid; Pyridoxine; Folic Acid; Inositol; Benphothiamine
Dosage : Capsule
Dosage Strength : 1000MCG; 200MG; 3MG; 1...
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
methylcobalamin; Pregabalin; Folic Acid; Pyridoxine; Benphothiamine
Brand Name :
Dosage Form : Capsule
Dosage Strength : 750MCG; 150MG; 750MCG;...
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
methylcobalamin; Pregabalin; Folic Acid; Pyridoxine; Benphothiamine
Dosage : Capsule
Dosage Strength : 750MCG; 150MG; 750MCG;...
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Market Place
Reply
01 Mar 2024
Reply
17 Feb 2024
Reply
12 Aug 2023
Reply
21 Jun 2023
Reply
16 Jun 2023
Reply
02 Mar 2023
Reply
16 Dec 2022
Reply
06 Sep 2022
ANALYTICAL
ABOUT THIS PAGE
A Benfotiamine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Benfotiamine, including repackagers and relabelers. The FDA regulates Benfotiamine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Benfotiamine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Benfotiamine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Benfotiamine supplier is an individual or a company that provides Benfotiamine active pharmaceutical ingredient (API) or Benfotiamine finished formulations upon request. The Benfotiamine suppliers may include Benfotiamine API manufacturers, exporters, distributors and traders.
click here to find a list of Benfotiamine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Benfotiamine DMF (Drug Master File) is a document detailing the whole manufacturing process of Benfotiamine active pharmaceutical ingredient (API) in detail. Different forms of Benfotiamine DMFs exist exist since differing nations have different regulations, such as Benfotiamine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Benfotiamine DMF submitted to regulatory agencies in the US is known as a USDMF. Benfotiamine USDMF includes data on Benfotiamine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Benfotiamine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Benfotiamine suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Benfotiamine Drug Master File in Japan (Benfotiamine JDMF) empowers Benfotiamine API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Benfotiamine JDMF during the approval evaluation for pharmaceutical products. At the time of Benfotiamine JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Benfotiamine suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Benfotiamine Drug Master File in Korea (Benfotiamine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Benfotiamine. The MFDS reviews the Benfotiamine KDMF as part of the drug registration process and uses the information provided in the Benfotiamine KDMF to evaluate the safety and efficacy of the drug.
After submitting a Benfotiamine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Benfotiamine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Benfotiamine suppliers with KDMF on PharmaCompass.
A Benfotiamine written confirmation (Benfotiamine WC) is an official document issued by a regulatory agency to a Benfotiamine manufacturer, verifying that the manufacturing facility of a Benfotiamine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Benfotiamine APIs or Benfotiamine finished pharmaceutical products to another nation, regulatory agencies frequently require a Benfotiamine WC (written confirmation) as part of the regulatory process.
click here to find a list of Benfotiamine suppliers with Written Confirmation (WC) on PharmaCompass.
Benfotiamine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Benfotiamine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Benfotiamine GMP manufacturer or Benfotiamine GMP API supplier for your needs.
A Benfotiamine CoA (Certificate of Analysis) is a formal document that attests to Benfotiamine's compliance with Benfotiamine specifications and serves as a tool for batch-level quality control.
Benfotiamine CoA mostly includes findings from lab analyses of a specific batch. For each Benfotiamine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Benfotiamine may be tested according to a variety of international standards, such as European Pharmacopoeia (Benfotiamine EP), Benfotiamine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Benfotiamine USP).
LOOKING FOR A SUPPLIER?